|Podcasts|September 15, 2011
INC's CEO Discusses the Current CRO Climate
Jim Ogle, CEO of INC Research, offers his take on industry consolidation, what it means for the future, and INC's own role and strategy in its recent acquisitions.
Advertisement
INC’s CEO Discusses the Current CRO Climate
Jim Ogle, CEO of INC Research, offers his take on industry consolidation, what it means for the future, and INC’s own role and strategy in its recent acquisitions.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
2
How the FDA’s CNPV Program Is Reshaping Trial Operations and Accelerated Review Strategies
3
Voyxact Lands FDA Accelerated Approval Following Positive Results in Phase III VISIONARY Trial
4
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
